Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
References
On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.
On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.
Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”
Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfonta
For more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta
The Disciplinary Committee has directed that Kfir Segev be restored to the RCVS Register, having removed him over two years ago for dishonesty and misleading clients.
Mr Segev, formerly practising in Stanmore, Middlesex, was removed from the Register following an 11-day hearing ending on 19 May 2009 at which he had been proven guilty of deliberately concealing from his clients that their dog was terminally ill, whilst at the same time recommending that she undergo expensive and unnecessary procedures.
This was Mr Segev’s first application for restoration to the Register. The Committee found that, during his period of removal, he had undergone “extensive personal and professional rehabilitation”, which included attendance at a clinical psychologist and voluntary work in the local community.
The Committee found that, during his period of removal, he had undergone "extensive personal and professional rehabilitation.
From 2009 to September 2011, Mr Segev logged 420 hours of certificated continuing professional development, with particular emphasis on ethics, client relationships and animal welfare.
The Committee noted he had also seen practice and taken the advice of mentors, including about 80 days at “a number of high quality practices with eminent members of the profession”.
These included Professor Dick White MRCVS, of Dick White Referrals, Professor David Noakes FRCVS, Emeritus Professor of the Royal Veterinary College and Mr David Grant MBE FRCVS, Hospital Director at the RSCPA Sir Harold Harmsworth Memorial Hospital, all of whom gave evidence at the hearing in support of Mr Segev.
Professor White said that, since late 2009 when he was approached by Mr Segev for help in remedial training, continuing education and mentoring, he had subsequently had frequent dealings and conversations with him.
Professor White said: “I formed the opinion that he invariably exercised professional clinical judgement that is, if anything, considerably deeper than many professional colleagues. I felt he demonstrated compassion for patients and empathy for owners in equal measure and believed him to have come to understand fully the seriousness of his behaviour."
Mr Segev’s efforts at rehabilitation were described as “exceptional” by Professor Noakes, who said he was “impressed by Mr Segev’s genuine acceptance of the fact that he had committed a serious offence and deserved to be punished.”
Mr Grant, who had been in contact with Mr Segev since November 2010, told the hearing that, in his opinion, it was most evident that Mr Segev accepted his wrongdoing and, along with Professor Noakes, indicated that he was willing to offer continued support and help.
The College opposed the restoration of Mr Segev on three grounds, namely: the gravity of the matters found proved at the original hearing; that the length of time off the Register was insufficient to mark these and ensure that the reputation of the profession was not undermined in the eyes of the public; and, Mr Segev’s conduct, relying on two matters arising from the footage in a BBC Panorama programme, which was filmed both before and after the 2009 hearing.
The College also questioned whether Mr Segev genuinely accepted the original findings.
The Committee agreed that the findings of the original hearing were serious; it was, however, impressed by Mr Segev’s complete and genuine written and public apologies for what he had done.
It disagreed that the length of time off the Register was too short.
It was mindful that the purpose of the sanction of erasure is not primarily of punishment and considered that no useful purpose would be served by delaying further Mr Segev’s restoration.
Whilst the Committee found Mr Segev was wrong to have continued to display ‘veterinary surgeon’ on the practice nameplate (as shown in the television footage), it was satisfied that he did not intend to hold himself out as a practising veterinary surgeon and no harm to the public or animal welfare resulted from his mistake.
The footage also showed Mr Segev was in breach of RCVS guidance on the administration of anaesthesia by permitting a student veterinary nurse to induce anaesthesia by using incremental doses of intravenous propofol, with an unqualified assistant offering advice on the depth of anaesthesia during its incremental induction. The Committee considered Mr Segev’s actions to be an error, now cured.
In conclusion, the Committee accepted Mr Segev “had made genuine and successful attempts to reform his previous attitude and failings”.
It noted that a large number of testimonials had been provided by colleagues, friends and clients, and that the impact of removal on Mr Segev had been severe.
It concluded that his previous mistakes provided “no reason, relevant to animal welfare, to suggest that his restoration would be unwise.”
Speaking on behalf of the Committee, Chairman Beverley Cottrell said: “Restoration to the Register of a veterinary surgeon who has been guilty of disgraceful conduct in a professional respect of such seriousness is not something to be undertaken lightly … But, in all the circumstances of this case, [we have] decided that Mr Segev is a fit person to restore to the Register, and so direct the Registrar.”
The programme gives farmers and veterinary surgeons access to new resources, enabling a coordinated and consistent approach to farmer training in the responsible use of antibiotics.
The development of the AMBP Programme has been led by NOAH in partnership with a group of stakeholders from across the industry including farmers, vets, the Responsible Use of Medicines in Agriculture Alliance (RUMA), the Veterinary Medicines Directorate (VMD), the British Retail Consortium (BRC) and leading academics, to create a training programme for all those working in the sheep, dairy, beef and pig sectors.
NOAH says the programme will raise awareness, knowledge and understanding of antimicrobial resistance (AMR) and help drive best practice in a consistent manner across UK farms when it comes to using antibiotics.
Training modules are available for farmers to access via the NOAH website or directly through an online Lantra eLearning platform.
In addition to the direct farmer offering, veterinary surgeons will also be to access resource materials, enabling them to deliver training to their clients. This veterinary resource centre will follow soon.
NOAH Chair, Gaynor Hillier, said: "We know that there is a real demand for this type of accessible training and we’re delighted to be able to lead the way in making it available.
"This new collaborative, cross-sector strategy on training will support both farmers and vets, demonstrating that our farmers have the skills to use antibiotics responsibly, providing reassurance to consumers and policy makers. NOAH is happy to be building on existing antibiotic stewardship achievements within the farming sector as ensuring best practice is vital to safeguard the future efficacy of antibiotics for us all.”
Biosecurity Minister Lord Gardiner said:
"The UK is at the forefront of global efforts to tackle antibiotic resistance. Recent statistics show there has been a 27 per cent drop in use of antibiotics in food-producing animals in the UK since 2014 - meeting a government commitment two years early.
"Our farmers and vets must be commended for driving down antibiotic use in livestock to this all-time low - setting an excellent example for others around the world to follow. But it is vital we continue making progress.
"We welcome this new responsible use of antibiotics farmer training programme, which will support the animal medicines industry to take another positive step towards tackling resistance, safeguarding antibiotics for future generations."
Photo: Lord Trees introduced the launch event and outlined his support for the AMBP programme.
If you buy 12 bags from the listed Veterinary Care Nutrition and Satiety Range, you'll get three outers of feline wet food free. Order a minimum of 12 bags and you'll also get a free standing display unit, twelve 50th Anniversary tins and a 50th Anniversary promotional pack. If you buy another eight bags from the listed Canine and Feline Veterinary Care Nutrition and Clinical range, you'll get one box of 12 Anniversary Tins free.
The 50th anniversary promotion pack includes bunting, a window cling, bag stickers and posters.
Erin Biss, Marketing Executive at Royal Canin, said: "50 years on, we continue to put science at the heart of everything we do. From our specially developed diets, to investment in education, supporting important research projects and collaborating with the UK’s universities. We hope vet practices around the UK will join us in celebrating this milestone.”
For more information about Royal Canin's 50th anniversary offer, speak to your Veterinary Business Manager.
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).
Billed as an essential reference, the new guide gives practical information on pain management in a wide range of small animals, emphasizing patient welfare and evidence-based medicine.
The BSAVA Guide to Pain Management in Small Animal Practice is edited by Ian Self, an RCVS and European Specialist in Veterinary Anaesthesia and Analgesia.
Each chapter is written by a specialist in the field, and the guide includes 'Authors’ perspectives' and case examples.
The first six chapters cover key areas in pain management, including the physiology of pain, acute and chronic pain, and pharmacological and physical treatment of pain. The remaining chapters look at specific types of pain, and pain in species commonly encountered in small animal practice.
Ian said: "This Guide is not to be seen as an instruction manual, rather a helping hand. For each case discussed and analgesic approach explained, there are multiple valid alternative approaches… when seeking inspiration or information when faced with a patient in pain, we hope that the information presented here will assist in reaching a satisfactory clinical outcome."
The new book will be given to eligible vet and vet nurse members free of charge as part of the Association's loyalty scheme; a 'thank you' for staying a member for another year. Further details are available from the member benefits section of the BSAVA website.
Both veterinary professionals and clients can nominate people and practices for one of five awards.
Every professional nominated in the awards will be sent a personalised certificate.
An independent panel of judges from within the veterinary industry will then narrow down the entries to a shortlist of three finalists for each award, who will all be invited to awards ceremony in Manchester on Thursday 21st March 2024.
Bella von Mesterhazy, Sales and Marketing Director at Petplan, said: “Every year we think we’ve seen it all, but then we’re overjoyed by the sheer volume of and enthusiasm behind the latest nominations.
"So for anyone who’s considered nominating before but hasn’t got round to it, this year’s the time to get involved, as we all come together to champion the immense success of the UK’s veterinary industry, whilst celebrating the awards quarter-century anniversary.”
petplan.co.uk/vetawards
Nominations close on 8th January 2024.
Ceva says the new product is the fruit of research into the composition of the main feline pheromones which pass through the incisive ducts to the Vomeronasal Organ (VNO), which in turn led to the discovery of a new pheromone complex which 'provides an enhanced message of social confidence and safety in the cat’s environment by conveying more impactful messages to it'.
According to the company, Feliway Optimum helps cats with more signs of stress, in more situations and calms cats better than ever. The product is proven to help with more stress-related signs faster than existing pheromones, with all signs of stress showing continuous improvement until day 28 of use and are visible from day 71. These include scratching, urine spraying, multi-cat tensions and conflicts and changes and fears.
Feliway Optimum is available as a plug-in diffuser with 30-day refills.
Abigail King, senior behaviour product manager at Ceva Animal Health said: "We have led the way with research for over 20 years with Feliway Classic and Feliway Friends, but it is now time to go that step further.
"Feliway Optimum is an extremely exciting addition to the range which will help solve all common signs of stress to provide enhanced serenity in a household.
"Nearly 60 per cent of cats show visible signs of stress2 and Feliway Optimum will really help combat this with an over 70% reduction”.
There is a webinar about the new product, presented by Professor Patrick Pageat and Dr Andy Sparkes, which is available by emailing Ceva.
For more information, visit www.feliway.com/uk, call Ceva on 01494 781510 or email cevauk@ceva.com.
According to the company, a similar percentage of respondents believe that senior cats would benefit clinically if they monitored blood pressure routinely in their senior years, and nearly 85% said that anti-hypertensive medication would increase the quality of life for their patients.
Time constraints were cited as the main barrier to routinely measuring blood pressure, but all of those questioned would be happy for a trained RVN to measure blood pressure in cats.
Ceva highlights studies which show show that hypertension affects one in eight cats over nine years old3, with the risk increasing as cats age or if they have other conditions such as chronic kidney disease (where one in three cats suffer with hypertension) or overactive thyroid disease (where an estimated one in four cats suffer with hypertension)4, 5, 6.
Rosanne Jepson, specialist in small animal internal medicine at the Royal Veterinary College said: "High blood pressure can cause severe damage to key body organs including the eyes, kidneys, heart and brain. Unfortunately, it is a condition that develops insidiously without early warning signs for the cat owner; a cat may seem perfectly fine until either the blood pressure is checked, or serious consequences of hypertension suddenly occur."
With this in mind, Ceva says it will host the first Feline Hypertension Month this May, to raise awareness of hypertension and improve the detection and management of high blood pressure in cats.
The company is also encouraging practices to take part in the 'Mercury Challenge', a study it is launching in the summer which will, it says, be the largest-ever European study into feline hypertension.
For information on feline hypertension, Feline Hypertension Month or the Mercury Challenge, contact your local Ceva Animal Health account manager.
So, it suggested, "Kill two birds with one stone" should become "Feed two birds with one scone", "Taking the bull by the horns" should become "Take the flower by the thorns", and "Bring home the bacon", "Bring home the bagels."
Oh honestly. This really gets my goat.
The elephant in the room, of course, is that there's always more than one way of skinning a cat.
Still, PETA went to the dogs years ago.
The study “Evaluation of quick sequential organ failure scores in dogs with severe sepsis and septic shock1” reviewed electronic records from dogs that presented through the veterinary medical teaching hospital emergency service between January 2010 and December 2019 using the search terms “sepsis” or “septic”.
The quick sequential organ failure score was calculated by evaluating respiratory rate (>22 breaths per minute), arterial systolic blood pressure (≤100mmHg) and altered mentation.
Forty-five dogs with severe sepsis and septic shock and 45 dogs with non-infectious systemic inflammatory response syndrome were included in the final analysis.
It was found that the quick sequential organ failure assessment score provided poor discrimination between survivors and non-survivors for dogs with severe sepsis and septic shock.
In addition, the quick sequential organ failure score demonstrated a poor sensitivity and fair specificity to detect this population of canine patients.
The authors say that previous studies on quick sequential organ failure score have provided conflicting results, but that this may just be due to the inherent heterogeneity of the population.
Considering the results of this study, it may not be possible to identify a single scoring system that serves the purpose that quick sequential organ failure assessment is intended for.
Nicola Di Girolamo, Editor of the JSAP said: “The results of this study have strong clinical implications.
"The JSAP values studies with negative findings such as this one, as much as studies with positive findings.
"The fact that a diagnostic tool or a treatment does not reach the desired objective, should not hinder publication of methodologically sound research”
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsap.13522
Reference
Virbac says Michelle is widely recognised as one of the world’s leading experts in companion animal reproductive biology.
She graduated from Washington State University College of Veterinary Medicine, before completing a residency at Cornell University and becoming board-certified in Theriogenology.
She earned a PhD in physiology at Cornell University and is currently a Full Professor at Oregon State University.
Michelle is also a member of the WSAVA Reproduction Control Committee which recently previewed its new Global Guidelines for Reproduction Control during WSAVA Congress in September.
Dr Neil Mottram MRCVS, Technical Manager at Virbac said: "The UK has the highest rate of surgical castration in Europe, but with new WSAVA global reproduction control guidelines expected to be published imminently, increasing evidence on the effect of surgical castration on long-term health and even the UK’s leading animal welfare charities updating their guidance on neutering dogs, there’s no better time to review practice neutering policies.
"In line with an evidence-based approach, we want to pose the question: is surgical castration right for every dog?"
www.bit.ly/caninecastration
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
Idexx has launched Pet Resist (www.petresist.com), an online map of the levels of antibiotic resistance recorded in cats and dogs by the company over the past five years.
The map displays geographical variations in resistance to the top 10 antibiotics used in cats and dogs.
Simon Wootton, UK CAG Marketing Manager from Idexx said: "The ability to select the most appropriate antibiotic prior to testing may increase the effectiveness of treatments and reduce the number of return visits. We believe that this new service will also help prolong the effective life of existing antibiotics at a time when there is considerable pressure on the profession to reduce their use."
Pet Resist shows levels of resistance overlaid on an interactive UK map down to individual postcode areas. You enter the postcode, the antibiotic (amoxicillin, ampicillin, cefaliexn, etc) and the suspected organism (E coli, S aureus, etc), after which you'll be able to see the level of resistance based on historical data from the past five years, and use this to help choose appropriate therapies.
Simon added: "We have used results of MIC tests on over 200,000 samples submitted to Idexx to develop the database upon which the resistance levels are based. The data will be continually updated as we receive more samples at our Wetherby laboratory, further increasing the accuracy and value of the service to vets and their clients."
Now, when you search Google for something which includes the word 'job' or 'jobs', Google presents an easy-to-filter list of local vacancies. You can also search in other locations.
One of the criteria for a job advert to be listed in Google for Jobs is that it must first have appeared on a webpage written with special code which allows the search engine to read the advert correctly.
VetSurgeon Jobs has been upgraded to include this code, and jobs advertised on VetSurgeon.org are now appearing on Google for Jobs.
VetSurgeon Editor Arlo Guthrie said: "We've known this was coming for some time, so we made sure VetSurgeon Jobs would be ready as soon as Google unveiled the new system.
"It has yet to be seen how widely Google for Jobs will be used by veterinary surgeons looking for a job. Back in the day, you'd have to wait for the latest copy of Vet Times to arrive in the post in order to find a job. Then came the internet, and with it a small handful of job websites worth checking for veterinary vacancies, of which VetSurgeon Jobs is one.
"Now, Google for Jobs provides one-stop search from most of the big players, although not all veterinary job boards are compatible with the new system and notably Indeed is excluded from Google for Jobs search results.
"The question now is whether jobseekers will continue to go directly to their favourite job website, or search Google first. Either way, though, you'll find jobs advertised on VetSurgeon.org!"
What do you think of the new Google for Jobs feature? Comment below.
For the study1, treatment and outcomes of ureter injuries due to ovariohysterectomy complications in cats and dogs was undertaken at the Royal Veterinary College. A retrospective case series of cats and dogs with ureteric injuries resulting from ovariohysterectomy was obtained from patient records at the Queen Mother Hospital for Animals. Fourteen female cats and five female dogs were included in the analysis. Descriptive statistics were used to report presenting clinical signs, clinical pathology, treatment and outcomes.
Professor Vicky Lipscomb, lead author of the paper, said “Presenting clinical signs of ureter injury following neutering in this study were non-specific, such as anorexia, vomiting and lethargy. Importantly, the clinical signs consistently developed immediately or shortly after surgery in the majority of animals. Therefore, the appearance of one or more clinical signs following neutering should raise suspicion of a neutering complication.
"The overall outcome for the 19 animals was excellent in 13 (68%), good in one (5%), fair in one (5%) and poor in four (22%). Ureteroneocystostomy (ureteral re-implantation) is preferred to ureteronephrectomy (removal of kidney and ureter) to preserve renal function and is usually a requirement for bilateral ureteric injuries but carries a high complication rate resulting in additional surgery, albeit often with an excellent final outcome.”
Nick Jeffery, editor of JSAP said: “Ovariohysterectomy is a common surgical procedure in cats and dogs, but the procedure carries a (low) risk of injury to one or both ureters due to the close proximity of the female reproductive tract and the ureters. This research highlights the need for vigilance regarding clinical signs following neutering but demonstrates that surgical treatment of ureteric injuries can have good patient outcome."
The full article can be found in the March issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13100
Photo: Luisa Dormer BSAVA
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
The nurse, who admitted the charges against her, successfully applied for anonymity at the outset of the case, on the basis that the shock factor of the removal of the animals' heads could greatly upset members of the public and veterinary staff, leading to a backlash which would present a threat to her safety.
The Disciplinary Committee heard that the nurse, who was working as a locum, asked a permanent member of staff if she could take a couple of skulls from the strays, because she had a friend who 'cleaned up' dead strays and wildlife and displayed the skulls at home.
The College’s case was that the nurse’s actions amounted to serious professional misconduct because she failed to afford the dead animals with the respect and dignity they deserved, there was a risk to human health because she failed to comply with biosecurity measures, and her actions had the potential to undermine public confidence in the profession.
Although she admitted that her conduct fell short of what was expected, the nurse countered that her actions were not intended to be disrespectful to the animals, that she was an animal-lover who had three cats of her own, and that her actions were not malicious but misjudged.
Weighing up the case, the Committee found that the aggravating features of her conduct were around biosecurity and abuse of her professional position, while in mitigation it found that there was no financial gain in her actions and that it was a one-off incident.
Kathryn Peaty, chairing the Committee and speaking on its behalf, said: “The respondent’s conduct represented a biosecurity risk.
"Any body part would be in some degree of decomposition.
"As the cats were strays, it was unclear as to whether or not they had been in good health.
"Although the respondent transferred the body parts to her home and kept them in the freezer in cadaver bags, there was a risk that they could leak.
"In short, her actions were not without risk to human or animal health.
“The respondent abused her professional position.
"She had an obligation to treat the cadavers with respect.
"Her professional position gave her access to the cadavers.
"She abused her professional position by severing the cats’ heads and, using a scalpel, body bags and other equipment she pursued an interest of her own, rather than performed the role she was employed to undertake.
"Although she may say that she obtained permission to remove the cats’ heads from a permanent member of staff, she was a Registered Veterinary Nurse and therefore an autonomous professional.
"Whatever permissions she received should not have made her believe she had a licence to act as she did.”
Considering the appropriate sanction, the Committee took into account her relative youth and inexperience, the fact she made open and frank admissions at an early stage, the fact she made efforts to avoid a repetition of the behaviours, the insight she had shown into why her conduct was wrong, and the amount of time that had passed since her conduct relative to the total length of her four-year veterinary nursing career.
The Committee also considered positive character references from fellow veterinary nurses with whom she worked and trained.
Kathryn added: “The Committee considered that a reprimand was the sanction it should impose.
"A reprimand marks the Committee’s view of the respondent’s behaviour, thereby satisfying the public interest.
“The Committee did consider issuing a warning as to future conduct, but it had no concerns that the respondent would fail to follow the Code of Professional Conduct for Veterinary Nurses in the future.
"It therefore rejected a warning as an appropriate alternative.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary
The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability of the vaccine means many vaccinated stallions and teasers should now be able to have their six-monthly booster dose within the normal designated timeframe.
Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
505 people took part in the survey in August 2019, of which 85% were receptionists. The remainder were RVNs, VCAs or practice managers with some front desk responsibility.
The survey found that 45% were paid between £8 and £9 per hour, with 9% more falling into this salary bracket than in 2018. 5.32% were paid £8 or less per hour.
The Real Living Wage is a figure calculated from the costs of a basket of household goods and services by the Living Wage Foundation, and voluntarily paid by its 6000-odd member companies in the UK. The Living Wage Foundation argues it is a better measure of what people need to get by on than the Minimum Wage (£7.70 for those aged between 21 and 25) or the National Living Wage (£8.21 for those over 25).
63% of veterinary receptionists said they were unsatisfied with their pay. However, it was not the biggest cause of dissatisfaction uncovered by the survey. 67% were dissatisfied with the recognition of the value of their role, and 69% with the career progression options open to them.
70% of respondents said they would like to do more CPD and that the main benefit would be to clients and patients. However, 43% of receptionists said there is no time allowance set aside for them to complete CPD.
Co-founder of BVRA and Honorary Associate Professor In Veterinary Business, Nottingham University, Brian Faulkner (pictured right) said: "A large part of the client experience is centred around the waiting room and receptionist area and our members work hard to ensure that experience is positive.
"We have an increasing number looking to upskill and the appetite for CPD is clearly there. If we can envisage a scenario where the minimum wage is set at £10.50 an hour, that would mean that around 65% of veterinary receptionists would need a pay increase.
"I don't think any of us believe that veterinary receptionists are currently doing an unskilled job and a key mission of BVRA is to achieve greater recognition of the value they bring to practices, both as colleagues and commercially."
Taking place at Code Node, VSGD Live will bring together 300 veterinary professionals, offering TED-style talks, Q&A sessions, small group workshops, panel discussions, a VSGD art gallery, awards, and time for networking.
On day one, the event will explore the options open to veterinary surgeons, with talks from those who've stayed in practice, left the profession or diversified their career paths.
There to share their experiences will be Julie Ross (From the clinic to consultancy), Niall Connell (Discovering life after ill health retirement), James Greenwood (Presenter, vet, potter), Jade Statt (Starting Streetvet), Greg Dickens & Guen Bradbury (Work to innovate), Chris Tufnell (Advocating for the profession in practice), Rob Petitt (Mind over matter and surgery), Kimberly Wells (Talk is cheap action is priceless lessons from welfare and Cal Major (Paddling against plastic).
On day two, there will be small group workshops and panel discussions to help you build the confidence and knowledge to move into a new career path or gain a new skill. Subjects include:
Working out what you want: Vet Your Life!
Stop selling yourself short: CV clinic
Taking an idea to business
Practice makes perfect: Starting a veterinary business
Becoming a portfolio professional or a part-time pro
Working in science and communications
Careers in education
Carving out a charitable career
Beyond veterinary: working in the civil service
Locumming: be the independent professional
Lunch on both days is included, as well as drinks and nibbles on Saturday night.
All ticket holders will also receive a follow up e-book with top tips, videos and advice from the inaugural VSGD LIVE! event.
Eurovet Animal Health has announced that it is bringing a veterinary licensed vitamin K1 (phytomenadione) injectable preparation to the UK.
Eurovet says the new preparation, available from the wholesalers by Monday at the latest, will ensure that the previous supply problems of vitamin K1, will be overcome.
According to the company, the intravenous route is the only route to ensure a 100% bioavailability of vitamin K1 almost immediately and in a crisis situation is the best route of treatment. During anticoagulant poisoning, the coagulation factors are present in the body but are not functional. The faster vitamin K1 enters the blood flow, the quicker the coagulation function is restored.
Ruth Vernon, Technical Services Manager for Eurovet said: "We also plan to bring veterinary licenced vitamin K1 tablets to the UK market later in the year, allowing them to be ordered direct from veterinary wholesalers. The future continuity of supply represents a significant improvement on the current situation."
Anticoagulant rodenticide poisoning is the second most common query received by the VPIS. Alexander Campbell, Head of Service at VPIS, said: "The Veterinary Poisons Information Service receives well over 1000 telephone enquiries per annum from UK veterinary professionals seeking advice on how to manage potential and accidental exposures to anticoagulant rodenticides in a variety of animals - mainly pet dogs. Whilst most cases require basic assessment, first-aid and precautionary laboratory tests, an inevitable few develop serious intoxication and need long-term treatment. Vitamin K1 is a mainstay of therapy in these instances, and the availability of licensed veterinary-specific products in the UK is a major advance. Previously, preparations licensed for human use were often the only option when these could be sourced. Anything that ensures ready supply and facilitates speed of therapy for severe cases has to be welcomed."
There are over 500 anticoagulant rodent killing preparations available across Europe. They are available ready to use, as coated cereals, bait blocks, tracking powders, semolina formats or concentrates (which are reserved for professional use). Following cut backs in local council spending on pest control, the National Pest Technicians Association identified in a recent survey* that there is a 'worrying increase in poorly-managed DIY rodent control'.
*The NPTA National Rodent Survey 2009/2010
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.
The new course is called Veterinary Science: Accelerated Graduate Entry (BVSc), and will welcome its first students in September 2019.
The school says the course responds to calls for innovation in veterinary education while upholding current best practice in adult education to support independent, self-directed, and collaborative learning.
Designed for graduate learners, the programme will see students guided through case-based, tutor-facilitated teaching and learning.
The programme is based on a collaborative approach, where students can work together to gain practical experience from BVS clinics and clinical research.
Students will be taught in new purpose-built teaching facilities at the school in Langford, North Somerset.
The Langford Campus also encompasses equine and small animal hospitals, a dairy farm, diagnostic laboratories, and farm animal, small animal and equine practices.
Professor Richard Hammond, Head of Bristol Veterinary School said: "As someone who was a graduate entry veterinary student myself, I feel passionately about providing opportunities to those who make the choice to train as a vet later in their educational journey.
"This new programme, delivered in purpose built, state-of-the-art facilities will focus on a more student-centred, case-based approach in small groups and with lots of tutor contact and support. We look forward to welcoming our first cohort of students to Bristol in September 2019".